REPURPOSE.AI

Repurpose.AI was founded on a belief that many of these safe, yet efficacy-related failed drugs, could find new uses as therapies for rare diseases. They have developed a technology that is able to predict a novel mechanism of action for drug candidates, thereby breathing new life into these assets, and creating an opportunity to develop a therapy for a disease that otherwise wouldn’t be pursued.